
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+6
SINEW PHARMA INC. (stock code: 6634.TWO) is a publicly-listed biotech company dedicated on the development of therapeutic products for solving urgent and important unmet medical needs. SINEW aspires to become a leading pharmaceutical company by actively engaging in R&D for drug development of metabolic dysfunction-associated steatohepatitis, MASH (formerly known as non-alcoholic steatohepatitis, NASH) as well as for the worlds first non-hepatotoxic acetaminophen. Current pipeline includes six products, two of which are dedicated to MASH treatment, three aim to address liver toxicity issues arising from the widely used painkiller acetaminophen and its combinations (e.g., with a non-addictive kappa-opioid for postoperative pain...
Nash,hepatotoxicity-free acetaminophen,acetaminophen,collaboration,innovation,toxicology,clinical reserach,new drug development,new chemical entity,first-in-class drug,and pharmaceutical r&d
Sinew pharma inc operates in the Biotechnology research industry.
Sinew pharma inc's revenue is 11m - 100m
Sinew pharma inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.